ConductScience.org, home

Paper36909895

Concentrations of selected acute phase proteins in patients with chronic venous insufficiency treated with Sulodexide. Part 1.

Kaczmarek B and 5 others. Postepy Dermatol Alergol, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Concentrations of selected acute phase proteins in patients with chronic venous insufficiency treated with Sulodexide. Part 1. Papers, record 36909895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36909895

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Concentrations of selected acute phase proteins in patients with chronic venous insufficiency treated with Sulodexide. Part 1.
PubMed
Journal
Postepy Dermatol Alergol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2023-03-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaczmarek BBarbara
2Kozłowska MMagdalena
3Narbutt JJoanna
4Adamski ZZygmunt
5Adamska KKinga
6Kaszuba AAndrzej

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133807848Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review.Int J Mol Sci2021https://conductscience.org/library/papers/33807848PubMed
211296331In situ hemodynamics of perforating veins in chronic venous insufficiency.J Vasc Surg2001https://conductscience.org/library/papers/11296331PubMed
325246013The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.Circulation2014https://conductscience.org/library/papers/25246013PubMed
47494366Risk factors for chronic venous insufficiency: a dual case-control study.J Vasc Surg1995https://conductscience.org/library/papers/7494366PubMed
511511615Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study.Int J Epidemiol2001https://conductscience.org/library/papers/11511615PubMed
631989486Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis.Adv Ther2020https://conductscience.org/library/papers/31989486PubMed
718572373Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program.J Vasc Surg2008https://conductscience.org/library/papers/18572373PubMed
810536489The effect of glycosaminoglycan sulodexide on oxidative stress and fibrinolysis in diabetes mellitus.Sb Lek1998https://conductscience.org/library/papers/10536489PubMed
914718318Relationship between deep venous thrombosis and the postthrombotic syndrome.Arch Intern Med2004https://conductscience.org/library/papers/14718318PubMed
1015472590C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis.J Vasc Surg2004https://conductscience.org/library/papers/15472590PubMed
1131114584Evolution of C-Reactive Protein.Front Immunol2019https://conductscience.org/library/papers/31114584PubMed
1224936530Sulodexide: it is time for a program against chronic venous disease.Int Angiol2014https://conductscience.org/library/papers/24936530PubMed
1334019218A brief, highly selective history of acute phase proteins as indicators of infection, inflammation and injury.Inflammopharmacology2021https://conductscience.org/library/papers/34019218PubMed
1428688874The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease.Ann Vasc Surg2018https://conductscience.org/library/papers/28688874PubMed
1512936900Chronic venous disease in an ethnically diverse population: the San Diego Population Study.Am J Epidemiol2003https://conductscience.org/library/papers/12936900PubMed
1624936532Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease.Int Angiol2014https://conductscience.org/library/papers/24936532PubMed
1724279420
Sulodexide down-regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease.
Curr Vasc Pharmacol2014https://conductscience.org/library/papers/24279420PubMed
1810479629New insights into perforator vein incompetence.Eur J Vasc Endovasc Surg1999https://conductscience.org/library/papers/10479629PubMed
1915723761The epidemiology of chronic venous insufficiency and varicose veins.Ann Epidemiol2005https://conductscience.org/library/papers/15723761PubMed
201430543Predisposing factors of varicose and telangiectatic leg veins.J Dermatol Surg Oncol1992https://conductscience.org/library/papers/1430543PubMed

See all 32 referencesDownload CSV of references

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
BLOC1S2282991PubTator's text mininghttps://conductscience.org/library/genes/282991NCBI Gene
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
F122161PubTator's text mininghttps://conductscience.org/library/genes/2161NCBI Gene
F32152PubTator's text mininghttps://conductscience.org/library/genes/2152NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
ICAM13383PubTator's text mininghttps://conductscience.org/library/genes/3383NCBI Gene
IL1A3552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
MMP94318PubTator's text mininghttps://conductscience.org/library/genes/4318NCBI Gene
MPG4350PubTator's text mininghttps://conductscience.org/library/genes/4350NCBI Gene
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
SELP6403PubTator's text mininghttps://conductscience.org/library/genes/6403NCBI Gene
SERPINA15265PubTator's text mininghttps://conductscience.org/library/genes/5265NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36909895

GET https://conductscience.org/api/papers/v1/36909895/references?page=2